Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms

J Allergy Clin Immunol. 2019 Mar;143(3):1258-1261. doi: 10.1016/j.jaci.2018.11.011. Epub 2018 Nov 22.

¹ Department of Pathophysiology and Allergy Research, Medical University of Vienna, Waehringer Guertel, Vienna, Austria.
² Vienna Challenge Chamber, Huetteldorfer Straße, Vienna, Austria.
³ NRC Institute of Immunology FMBA of Russia, Moscow, Russia.
⁴ Department of Oto-Rhino-Laryngology, Medical University of Vienna, Vienna, Austria.
⁵ Department of Production, Landesapotheke Salzburg, Muellner Hauptstraße, Salzburg, Austria.
⁶ Allergy Center Vienna West, Huetteldorfer Straße, Vienna, Austria.
⁷ Vienna Challenge Chamber, Huetteldorfer Straße, Vienna, Austria; Allergy Center Vienna West, Huetteldorfer Straße, Vienna, Austria.
⁸ Department of Pathophysiology and Allergy Research, Medical University of Vienna, Waehringer Guertel, Vienna, Austria; NRC Institute of Immunology FMBA of Russia, Moscow, Russia; Laboratory for Immunopathology, Department of Clinical Immunology and Allergy, Sechenov First Moscow State Medical University, Moscow, Russia. Electronic address: [email protected].

No abstract available

Publication types